Radionetics Oncology Enters Into Strategic Agreement With Lilly

Jul 1, 2024 · Radionetics Oncology, a biotech company developing GPCR-targeted radiopharmaceuticals for cancer, enters into a deal with Lilly that gives Lilly exclusive rights to …

CouponFollow Extension

$140
OFF

Radionetics Oncology Enters Into Strategic Agreement With Lilly

4 weeks from now

Jul 1, 2024 · Under the terms of the agreement, Radionetics received a $140 million upfront cash payment. As part of the strategic arrangement, Lilly obtained the exclusive right to acquire …

businesswire.com

$140
OFF

Eli Lilly And Radionetics Oncology Enter $140m Radiopharma …

4 weeks from now

Jul 2, 2024 · Eli Lilly has agreed to pay Radionetics Oncology $140m upfront to partner on the biotech’s G protein-coupled receptor (GPCR)-targeting small-molecule radiopharmaceuticals. …

pmlive.com

$140
OFF

Lilly Signs $140M Upfront Partnership With Radionetics In Latest ...

4 weeks from now

Oct 10, 2024 · Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G …

biotech-today.com

$1
OFF

Eli Lilly Inks Another Radiopharma Deal, Gaining Option To Buy Startup

4 weeks from now

Jul 1, 2024 · Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 …

biopharmadive.com

$140
OFF

Lilly Signs Another Radiopharma Pact | C&EN Global Enterprise

4 weeks from now

Jul 15, 2024 · Eli Lilly and Company is backing another radiopharmaceutical developer, this time paying San Diego–based Radionetics $140 million up front to make drugs that target a family …

acs.org

$140
OFF

Lilly Inks Radiopharma Deal With Radionetics, With Rights To Buy The ...

4 weeks from now

Jul 1, 2024 · Eli Lilly is further delving into the radiopharmaceutical field with a $140 million upfront deal with Radionetics Oncology. The strategic pact with the San Diego biotech could turn into …

sdbn.org

$140
OFF

Lilly Enters $140 Million Radiopharmaceutical Pact

4 weeks from now

Jul 11, 2024 · Eli Lilly and Company is backing another radiopharmaceutical developer, this time paying San Diego–based Radionetics $140 million up front to make drugs that target a family …

acs.org

$140
OFF

Lilly Signs $140M Upfront Partnership With Radionetics In Latest ...

4 weeks from now

Lilly signs $140M upfront partnership with Radionetics in latest radiopharma play Biotech News 📰 fiercebiotech.com Open. Share Add a Comment. Be the first to comment Nobody's responded …

reddit.com

$140
OFF

Lilly Signs $140M Upfront Partnership With Radionetics In Latest ...

4 weeks from now

Jul 1, 2024 · Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G …

mwbn.bio

FAQs about Radionetics Oncology Enters Into Strategic Agreement With Lilly Coupon?

Will Lilly buy radionetics?

Radionetics to receive $140 million upfront payment Lilly obtains the exclusive right to acquire Radionetics for $1 billion Paul Grayson, CEO of Radionetics Oncology (Photo: Business Wire) ...

How much did Lilly pay radionetics?

Under the terms of the agreement, Radionetics received a $140 million upfront cash payment. As part of the strategic arrangement, Lilly obtained the exclusive right to acquire Radionetics upon conclusion of an exercise period for $1 billion. ...

Will Eli Lilly buy radionetics oncology for $140 million?

Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G protein coupled receptor (GPCR) targeted drugs. ...

Why is Lilly partnering with radionetics?

Jacob Van Naarden, president of Lilly oncology, in a statement said that the partnership with Radionetics gives the pharma “access to novel GPCR targets” and the robust discovery capabilities of the biotech. Radionetics focuses on the development small molecule radiopharmaceuticals. ...

What is Lilly's New radioligand pipeline?

The San Diego-based biotech is tasked by Lilly with generating a pipeline of radioligand therapeutics for solid tumours based on small molecules tethered to either alpha- or beta-particle-emitting radioisotopes. ...

Will Lilly buy crinetics?

The agreement also gives Lilly the option to buy the Crinetics spinout for a cool $1 billion at the end of an exercise period. Lilly dived into the nascent radiopharma space by acquiring Point Biopharma for $1.4 billion in late 2023. ...